Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
13
NMPA:13
Drug Approvals
Neostigmine Methylsulfate Injection
- Product Name
- 甲硫酸新斯的明注射液
- Approval Number
- 国药准字H20254142
- Approval Date
- May 13, 2025
NMPA
Neostigmine Methylsulfate Injection
- Product Name
- 甲硫酸新斯的明注射液
- Approval Number
- 国药准字H20254141
- Approval Date
- May 13, 2025
NMPA
Avatrombopag Maleate Tablets
- Product Name
- 马来酸阿伐曲泊帕片
- Approval Number
- 国药准字H20253548
- Approval Date
- Mar 4, 2025
NMPA
Procaterol Hydrochloride Inhalation Solution
- Product Name
- 盐酸丙卡特罗吸入溶液
- Approval Number
- 国药准字H20249043
- Approval Date
- Oct 9, 2024
NMPA
Procaterol Hydrochloride Inhalation Solution
- Product Name
- 盐酸丙卡特罗吸入溶液
- Approval Number
- 国药准字H20249042
- Approval Date
- Oct 9, 2024
NMPA
Dobutamine Hydrochloride Injection
- Product Name
- 盐酸多巴酚丁胺注射液
- Approval Number
- 国药准字H20244901
- Approval Date
- Sep 19, 2024
NMPA
Dopamine Hydrochloride Injection
- Product Name
- 盐酸多巴胺注射液
- Approval Number
- 国药准字H20234554
- Approval Date
- Nov 28, 2023
NMPA
Oseltamivir Phosphate Granules
- Product Name
- 磷酸奥司他韦颗粒
- Approval Number
- 国药准字H20233979
- Approval Date
- Aug 1, 2023
NMPA
- Prev
- 1
- 2
- Next
Clinical Trials
No trials found
News
No news found